Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population — Wayne C. Levy (2009) | RDL Network
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
Article 2009 en
Authors
WL
Wayne C. Levy
KL
Kerry L. Lee
AH
Anne S. Hellkamp
Abstract
1 min read
A clinical risk prediction model identified subsets of moderately symptomatic heart failure patients in SCD-HeFT in whom single-lead ICD therapy was of no benefit and other subsets in which benefit was substantial.
Robert W. Rho, Kristen K. Patton, Jeanne E. Poole, John G.F. Cleland, Ramin Shadman, Inder S. Anand, Aldo Maggioni, Peter E. Carson, Karl Swedberg, Wayne C. Levy
C. Jan Willem Borleffs, Lieselot van Erven, Rutger J. van Bommel, Enno T. van der Velde, Ernst E. van der Wall, Jeroen J. Bax, Frits R. Rosendaal, Martin J. Schalij
C. Jan Willem Borleffs, Guido H. van Welsenes, Rutger J. van Bommel, Enno T. van der Velde, J BAX, L. van Erven, Hein Putter, Johanna G. van der Bom, Frits R. Rosendaal, M.J. Schalij
Norman C. Wang, Jonathan P. Piccini, Marvin A. Konstam, Aldo Maggioni, Brian Traver, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Thomas D. Cook, Christopher M. O’Connor, Alan B. Miller, Liliana Grinfeld, Mihai Gheorghiade
Valeria Rella, N Maurizi, Andrea Bernardini, Francesco Brasca, S. Salerno, Manjula Meda, Diana Mariani, Margherita Torchio, Giulio Conte, A Auricchio, Gianfranco Parati, Iacopo Olivotto, Giovanni Battista Perego, Franco Cecchi, Lia Crotti
Discussion(0)
No comments yet. Be the first to comment.